文献速递主动脉疾病

无并发症急性和亚急性B型主动脉夹层TEVAR术后与保守治疗相比的有利重构:中期分析

Favorable Remodeling After TEVAR in Uncomplicated Acute and Subacute Type B Aortic Dissection in Comparison to Conservative Treatment: A Midterm Analysis.
PubMed 文献 · J Endovasc Ther · 2023-03-08

该回顾性单中心分析比较了35例高风险无并发症急性和亚急性B型主动脉夹层患者接受TEVAR与18例保守治疗患者的中长期结局;TEVAR组主动脉和假腔最大直径显著减小、真腔直径显著增加(各p<0.001),3年估计生存率94.1%、5年87.5%,无30天和院内死亡。

要点

  • TEVAR组随访中位34个月,主动脉和假腔最大直径显著减小、真腔直径显著增加(各p<0.001)。
  • TEVAR组完全假腔血栓形成从术前6%增至随访时60%。
  • TEVAR组3年和5年估计生存率分别为94.1%和87.5%。

核心结论

  • 对后续主动脉并发症高风险的无并发症急性和亚急性B型主动脉夹层患者,TEVAR安全且与有利的中期主动脉重构相关。

研究设计与样本

  • 回顾性分析及随访研究,纳入2008年至2019年因无并发症急性和亚急性B型主动脉夹层接受TEVAR的35例患者和同期保守治疗的18例患者。
  • 共纳入53例患者(女性22例),平均年龄61.1±13岁。

主要发现

  • TEVAR组随访中位34个月,主动脉最大直径、假腔直径显著减小,真腔直径显著增加(各p<0.001)。
  • TEVAR组完全假腔血栓形成从术前6%增至随访时60%。
  • TEVAR组主动脉、假腔和真腔直径的中位差值分别为-5 mm(IQR=-28至8 mm)、-11 mm(IQR=-53至10 mm)和7 mm(IQR=-13至17 mm)。
  • TEVAR组3例(8.6%)需再干预,随访中2例死亡(其中1例主动脉相关);Kaplan-Meier分析估计3年生存率94.1%、5年生存率87.5%。
  • 保守组无30天和院内死亡,随访中2例死亡、5例(28%)转为TEVAR;随访中位26个月(范围=150),主动脉最大直径显著增加(p=0.006),假腔有增大趋势(p=0.06),真腔未见显著减小。

临床怎么用

  • 作者认为,对后续主动脉并发症高风险的无并发症急性和亚急性B型主动脉夹层患者,TEVAR安全且与有利的中期主动脉重构相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of the study was to evaluate the midterm and long-term outcomes of patients who underwent thoracic endovascular aortic repair (TEVAR) procedure to treat an uncomplicated acute and subacute type B aortic dissection (uATBAD) with high risk for subsequent aortic complications compared with the group of patients who received a conservative treatment protocol during the same period. MATERIALS AND METHODS: Between 2008 and 2019, 35 patients who had TEVAR due to uATBAD and those with conservative procedure (n=18) were included in a retrospective analysis and follow-up study. The primary endpoints were false lumen thrombosis/perfusion, true lumen diameter, and aortic dilatation. The aortic-related mortality, reintervention, and long-term survival were the secondary endpoints. RESULTS: In the study period, 53 patients (22 females) with a mean age of 61.1±13 years were included. No 30-day and in-hospital mortality was recorded. Permanent neurological deficits occurred in 2 patients (5.7%). In the TEVAR group (n=35) and in a median follow-up period of 34 months, a significant reduction of maximum aortic and false lumen diameter as well as a significant increase of true lumen diameter were detected (p<0.001 each). Complete false lumen thrombosis increased from 6% preoperatively to 60% at follow-up. The median difference in aortic, false lumen, and true lumen diameter was -5 mm (interquartile range [IQR]=-28 to 8 mm), -11 mm (IQR=-53 to 10 mm), and 7 mm (IQR=-13 to 17 mm), respectively. In 3 patients (8.6%), a reintervention was needed. Two patients (1 aortic-related) died during follow-up. The estimated survival according to Kaplan-Meyer analysis was 94.1% after 3 years and 87.5% after 5 years. Similar to the TEVAR group, no 30-day or in-hospital mortality was recorded in the conservative group. During follow-up, 2 patients died and 5 patients underwent conversion-TEVAR (28%). In a median follow-up period of 26 months (range=150), a significant increase of maximum aortic diameter (p=0.006) and a tendency to augmentation of the false lumen (p=0.06) were noted. No significant reduction of the true lumen was seen. CONCLUSIONS: Thoracic endovascular aortic repair in patients at high risk of subsequent aortic complications in uncomplicated acute and subacute type B aortic dissection is safe and is associated with favorable midterm outcomes regarding aortic remodeling. CLINICAL IMPACT: In a retrospective, single center analysis of prospectively collected data with follow-up, we compared 35 patients with high-risk features who recieved TEVAR in acute and sub-acute uncomplicated type B aortic dissection to a control-group (n=18). The TEVAR group showed a significant positive remoduling (reduction of max. aortic and false lumen diameter and increase of true lumen diameter (p<0.001 each)) during follow-up with an estimated survival of 94.1% after 3 years and 87.5% after 5 years.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Ahmad W, Brunkwall J, Bunck AC, et al. Favorable Remodeling After TEVAR in Uncomplicated Acute and Subacute Type B Aortic Dissection in Comparison to Conservative Treatment: A Midterm Analysis. J Endovasc Ther. 2023. PMID: 36891635. doi:10.1177/15266028231158971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。